Clinical trial
The IMAP Study Improving Management of Mildly Abnormal Pap Smears
NCT00119509 · University of Sydney, Other · Unknown status
Key facts
| NCT number | NCT00119509 |
|---|---|
| Title | The IMAP Study Improving Management of Mildly Abnormal Pap Smears |
| Official title | HPV DNA Testing Versus Conventional Management for Women With Minor Atypia on Pap Smear: Psychosocial and Quality of Life Outcomes and Development of a Decision Analytic Model |
| Lead sponsor | University of Sydney, Other |
| Collaborators | National Health and Medical Research Council, Australia Family Planning Association New South Wales |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervix Neoplasms |
| Intervention type | Procedure |
| Interventions | HPV DNA testing, Conventional management (repeat Pap smear at 6 months), Decision aid with choice of management |
| Enrollment | 300 |
| Start date | Jan 1, 2004 |
| Completion | Apr 1, 2008 |
| First posted | Jul 13, 2005 |
| Last update posted | Apr 25, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: